VanEck Associates
ENZY

VanEck Associates’s Enzymotec Ltd ENZY Stock Holding History

VanEck Associates’s Portfolio ENZY Stock Details ENZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,476
Closed -$41K – 773
2017
Q4 		$41K Sell
3,476
-2,704
-44% -$31.4K ﹤0.01% 706
2017
Q3 		$71K Buy
6,180
+276
+5% +$2.72K ﹤0.01% 639
2017
Q2 		$48K Sell
5,904
-3,560
-38% -$29.7K ﹤0.01% 724
2017
Q1 		$83K Hold
9,464
– – ﹤0.01% 769
2016
Q4 		$62K Sell
9,464
-3,241
-26% -$21.3K ﹤0.01% 768
2016
Q3 		$89K Buy
12,705
+46
+0.4% +$369 ﹤0.01% 730
2016
Q2 		$106K Buy
12,659
+706
+6% +$5.85K ﹤0.01% 681
2016
Q1 		$108K Buy
11,953
+69
+0.6% +$601 ﹤0.01% 667
2015
Q4 		$116K Sell
11,884
-1,755
-13% -$16.6K ﹤0.01% 609
2015
Q3 		$123K Buy
+13,639
New +$122K ﹤0.01% 606

VanEck Associates's ENZY Position: Q1 2018 in Review

VanEck Associates sold out of Enzymotec Ltd (ENZY) in Q1 2018, closing a stake of 3,476 shares — an estimated $41K sold.

VanEck Associates first reported a position in ENZY in Q3 2015 and held it in 10 quarters. The position peaked at $123K in Q3 2015. 0 funds tracked by Wall St. Rank hold ENZY as of Q1 2018.

  • VanEck Associates reported no remaining Enzymotec Ltd position as of Q1 2018 after selling out during the quarter.
  • VanEck Associates sold 3,476 Enzymotec Ltd shares in Q1 2018, an estimated $41K.
  • VanEck Associates first reported a position in Enzymotec Ltd in Q3 2015 and held it in 10 quarters.
  • VanEck Associates's Enzymotec Ltd position peaked at $123K in Q3 2015.
  • 0 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q1 2018.

Based on VanEck Associates's 13F filing for Q1 2018, filed 11 May 2018.